Reminder
The information contained in the below links is for the sole purpose of use and knowledge of RMPs only and intended to guide such RMPs in respect of matters relating to (a) therapeutic indication of the respective drug (b) its administration (c) its dosage (d) its side-effects and (e) the precautions to be observed in the treatment with the drugs.
These SMPC/PI are drug-specific technical documents that are part of every medicine’s marketing authorization. MSD has made them available on this website on the instructions of the relevant regulatory authorities, and nothing provided therein should be construed as medical advice.
Patients and their relatives should not access the information contained in this link and they are advised to consult their treating physicians.
GARDASIL® HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT